Impurity Profiling Using Convergence Chromatography and Mass Spectrometry

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-15-2013
Volume 2013 eBook
Issue 1

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling.

 

Coupling ultra-performance convergence chromatography to mass spectrometry provides an important tool for pharmaceutical analysis.

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling. This was achieved by using metoclopramide and its related substances and metoclopramide drug products as examples.

View 

Pharmaceutical Technology’s 2013 Analytical and Bioanalytical Testing ebook

.

 

 

 

Articles in this issue
pt-ebook_chrom.jpg
Impurity Profiling Using Convergence Chromatography and Mass Spectrometry
pt_ebooks_nmr.jpg
Multiple Reaction Monitoring–Mass Spectrometry for Biopharmaceutical Analysis
pt_ebooks_lcms.jpg
Simultaneous Quantitative and Qualitative Measurements in Drug-Metabolism Investigations
pt_ebooks_protein.jpg
Identification and Quantification of Trace-Level Protein Impurities
pt_ebooks_hplc.jpg
Ultra-High-Speed Analysis of Ibuprofen Using HPLC
pt_ebooks_microscopy.jpg
Characterization with Atomic Force Microscopy, Topographic, and 3D Raman
Recent Videos
Lee Cronin, founder and CEO of Chemify
Drug Digest: Is Our Understanding of Stability Changing
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Expands Analytical Services with GMP Cell-Based Potency Testing in US and UK

Feliza Mirasol
November 22nd 2024
Article

The company has expanded its early and late phase analytical capabilities by including GMP cell-based potency assays at its sites in Cambridge, UK, and San Diego, Calif.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges

Feliza Mirasol
November 15th 2024
Article

Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces.

Two scientists wearing lab coats and safety glasses analyzing data displayed on a computer screen in a laboratory setting | Image Credit: © NCST Studio - © NCST Studio - stock.adobe.com

Untethered Data: Unifying and Contextualizing Drug Discovery Data

Chris Stumpf
November 5th 2024
Article

Capturing and curating R&D data are crucial to realizing the full value of advanced analytics.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Expands Microbiology Laboratory Space

Susan Haigney
October 30th 2024
Article

The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.

People, mask or scientists on tablet in laboratory for results, life extension or antiaging medicine. Teamwork, vial or biologists with chemistry research, test tube or science information update |Image Credit: ©peopleimages.com - ©peopleimages.com-stock.adobe.com

Unifying and Contextualizing Drug Discovery Data

Chris Stumpf
October 16th 2024
Article

Collecting and curating R&D data are increasingly crucial tasks for achieving the full benefits of advanced analytics.